Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Clinical trial NCT04812379 · COMPLETED

Trial details

NCT number: NCT04812379
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Bipolar Disorder I

Start date: 2021-04-07
Primary completion: 2023-09-13
Enrollment: 535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.